Cognitive impairment in rheumatoid arthritis: role of lymphocyte subsets, cytokines and neurotrophic factors
- 25 January 2018
- journal article
- research article
- Published by Springer Nature in Clinical Rheumatology
- Vol. 37 (5) , 1171-1181
Abstract
To what extent the cognitive impairment of rheumatoid arthritis (RA) is modulated by autoimmune and/or inflammatory activity is largely unknown. The aim of this study was to investigate the role of peripheral inflammation on cognitive functions of patients with active (Ac-), controlled (Co-) RA and healthy controls. In a cross-sectional study, 102 RA patients and 30 matched healthy controls were recruited. B and T cell subsets were immunophenotyped by flow cytometry. Plasma cytokines and neurotrophins were measured by flow cytometry and ELISA, respectively. Cognitive performance, depression and stress were evaluated by structured clinical interviews. Generalized linear modeling (GzLM) was used to compare differences between groups and multiple linear regression models were used to explore the predictive value of immune variables on cognitive performance. RA patients had overall cognitive impairment. Of note, the Ac-RA had the poorest performance on digit span (DST) and N-back when compared to Co-RA and control group (DST 9.9 ± 2.1, 12.9 ± 4.2, 15.5 ± 4.7, respectively; N-back 49.2 ± 8.3, 55.5 ± 11.1, 60.8 ± 9.1, respectively, all p < 0.0001). RA patients had expansions of immature B cells (Ac-RA 11.2 ± 7.1, Co-RA: 9 ± 5.7, control 5.9 ± 2.1) and plasma cells (Ac-RA 5.2 ± 2.5, Co-RA 6.9 ± 3.7, control 2.8 ± 1.7) as compared to controls, all p < 0.05. RA patients (controlled and active disease) had higher plasma levels of TNF, IL-2, IL-4, IL-6 and IL-10 than controls (all p < 0.002). RA patients had higher BDNF levels (Ac-RA 17,354.4 ± 5357.3, Co-RA 13,841.2 ± 5953.7, control 11,543.3 ± 3772), but lower GDNF levels [median (interquartile range) Ac-RA 0 pg/ml (0.0), Co-RA 0 pg/ml (4.6) and control 4.7 pg/ml (18.1)] than controls (all p < 0.05). RA patients had global cognitive impairment, which was associated with disease activity and immune changes.Keywords
Funding Information
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (RGO 476468/2012-4)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (RGO 305141/2011-2, MEB 304528/2013-7)
- Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul (PqG 2044-2551/13-9SIAFEM)
This publication has 41 references indexed in Scilit:
- Cerebrospinal fluid inflammatory markers in Parkinson’s disease – Associations with depression, fatigue, and cognitive impairmentBrain, Behavior, and Immunity, 2013
- Assessment of biocorrelates for brain involvement in female patients with rheumatoid arthritisClinical Rheumatology, 2011
- Regulation of learning and memory by meningeal immunity: a key role for IL-4Journal of Experimental Medicine, 2010
- Glial cell line-derived neurotrophic factor is increased in cerebrospinal fluid but decreased in blood during long-term painJournal of Neuroimmunology, 2010
- Inflammatory markers and cognitive function in middle-aged adults: The Whitehall II studyPsychoneuroendocrinology, 2008
- Twenty years of research on cytokine-induced sickness behaviorBrain, Behavior, and Immunity, 2007
- Nerve Growth Factor and Brain‐Derived Neurotrophic Factor Levels in Patients with Rheumatoid Arthritis Treated with TNF‐α BlockersAnnals of the New York Academy of Sciences, 2006
- Immune cells contribute to the maintenance of neurogenesis and spatial learning abilities in adulthoodNature Neuroscience, 2006
- N‐back working memory paradigm: A meta‐analysis of normative functional neuroimaging studiesHuman Brain Mapping, 2005
- Activated Human T Cells, B Cells, and Monocytes Produce Brain-derived Neurotrophic Factor In Vitro and in Inflammatory Brain Lesions: A Neuroprotective Role of Inflammation?Journal of Experimental Medicine, 1999